Susana Clemente-Bautista

5PUBLICATIONS
22CO-AUTHORS
Infant and child healthCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 08, 2025
Long-Term Effectiveness and Safety of Proactive Therapeutic Drug Monitoring of Infliximab in Paediatric Inflammatory Bowel Disease: A Real-World Study.

Susana Clemente Bautista, Óscar Segarra Cantón, Núria Padullés-Zamora

|May 01, 2024
Use of oxazolidinones (linezolid or tedizolid) for the treatment of breast infections. A case series from a tertiary referral hospital.

Cristina Kirkegaard, Carlos Javier Parramón-Teixidó, Clara Morales-Comas

|Mar 20, 2024
The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model.

Susana Clemente-Bautista, Iñaki F Trocóniz, Óscar Segarra-Cantón

|Jan 21, 2023
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort.

Sara Salvador-Martín, Paula Zapata-Cobo, Marta Velasco

|Jan 12, 2021
Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease.

Sara Salvador-Martín, Bartosz Kaczmarczyk, Rebeca Álvarez

Pageof 1

Frequent Collaborators

2 joint publications

Víctor Manuel Navas-López

2 joint publications

Luis A López-Fernández

1 joint publications

Cesar Sánchez

1 joint publications

Antonio Millán-Jiménez